Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Daiichi Sankyo
UBS
Cerilliant
Cipla
Covington
AstraZeneca
US Department of Justice
QuintilesIMS

Generated: April 22, 2018

DrugPatentWatch Database Preview

RALOXIFENE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Raloxifene Hydrochloride patents expire, and when can generic versions of Raloxifene Hydrochloride launch?

Raloxifene Hydrochloride is a drug marketed by Amneal Pharms, Aurobindo Pharma Ltd, Glenmark Pharms Ltd, Invagen Pharms, Sciegen Pharms Inc, Teva Pharms Usa, and Watson Labs Inc. and is included in seven NDAs.

The generic ingredient in RALOXIFENE HYDROCHLORIDE is raloxifene hydrochloride. There are sixteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the raloxifene hydrochloride profile page.
Drug patent expirations by year for RALOXIFENE HYDROCHLORIDE
Pharmacology for RALOXIFENE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for RALOXIFENE HYDROCHLORIDE
Synonyms for RALOXIFENE HYDROCHLORIDE
(6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone hydrochloride
[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothien-3-yl][4-(2-piperidin-1-ylethoxy)phenyl]methanone hydrochloride
[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone hydrochloride
[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone;hydrochloride
[6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-methanone hydrochloride
[6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-methanone hydrochloride
[6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride
[6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone Hydrochloride
[6-hydroxy-2-(4-hydroxyphenyl)benzothiophen-3-yl]-[4-[2-(1-piperidyl)ethoxy]phenyl]methanone hydrochloride
[6-hydroxy-2[4-hydroxyphenyl)benzo [b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride
[6-hydroxy-2[4-hydroxyphenyl)benzo [b]thien3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride
[6-hydroxy-2[4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride
1-[2-(4-{[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]carbonyl}phenoxy)ethyl]piperidinium chloride
2-(4-hydroxyphenyl)-3-({4-[2-(piperidin-1-yl)ethoxy]phenyl}carbonyl)-1-benzothiophen-6-ol hydrochloride
2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol hydrochloride
4CA-1076
4F86W47BR6
6-hydroxy-2-(4-hydroxyphenyl)-3-[ 4-(2-piperidinoethoxy)benzoyl]benzo[b]thiophene, hydrochloride
6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]-benzo[b]-thiophene hydrochloride
6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]-benzo[b]thiophene hydrochloride
6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl 4-[2-(1-piperidinyl)ethoxy]phenyl methanone hydrochloride
6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl 4-[2-(1-piperidinyl)ethoxy]phenyl ketone hydrochloride
6-Hydroxy-2-(p-hydroxyphenyl)benzo(b)thien-3-yl-p-(2-piperidinoethoxy)phenyl ketone, hydrochloride
640R048
68523-EP2270008A1
68523-EP2292617A1
68523-EP2298768A1
68523-EP2308855A1
82640-04-8
84449-90-1 (Parent)
AB0020647
AC-8390
AC1L1HY9
AC1Q3F5K
AK-54611
AKOS008131940
AN-8061
ANW-54600
BC209548
BKXVVCILCIUCLG-UHFFFAOYSA-N
C28H27NO4S.HCl
C28H28ClNO4S
CAS-82640-04-8
CCG-213497
CDT-Raloxifene
CHEBI:50740
CHEMBL1116
CPD000058508
CS-1775
CTK7J9865
D02217
DS-2162
DSSTox_CID_14181
DSSTox_GSID_34181
DSSTox_RID_79119
DTXSID1034181
EN300-52517
EU-0101051
Evista
Evista (Raloxifene Hydrochloride)
Evista (TN)
Evista, Raloxifene hydrochloride
FT-0630912
HMS1570N05
HY-13738A
I06-1061
I14-1208
J90021
Keoxifene
Keoxifene HCl
Keoxifene hydrochloride
KS-00000JPS
KS-1102
Loxifen
LP01051
LS-91271
LY 156758
LY-156758
LY156758
M-8965
MCULE-7336063262
Methanone, (6-hydroxy-2-(4-hydroxyphenyl)benzo(b)thien-3-yl) (4-(2-(1-piperidinyl)ethoxy)phenyl)-, hydrochloride
Methanone, (6-hydroxy-2-(4-hydroxyphenyl)benzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)-, hydrochloride
Methanone, hydrochloride
MFCD01938233
MLS000859902
MLS001332533
MLS001332534
MLS002222293
NC00665
NCGC00015889-03
NCGC00015889-05
NCGC00015889-11
NCGC00092353-01
NCGC00092353-03
NCGC00094334-01
NCGC00094334-02
NCGC00255153-01
NCGC00261736-01
NSC-706725
NSC-759285
NSC706725
NSC759285
Optruma
Pharmakon1600-01505622
Prestwick_1035
Q-201656
R 1402
R0109
Raloxifene (hydrochloride)
Raloxifene Hcl
Raloxifene hydrochloride (JAN/USP)
Raloxifene hydrochloride [USAN:USP]
Raloxifene hydrochloride [USAN]
Raloxifene hydrochloride for peak identification, European Pharmacopoeia (EP) Reference Standard
Raloxifene hydrochloride, European Pharmacopoeia (EP) Reference Standard
Raloxifene Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Raloxifene hydrochloride, solid
Raloxifene hydrochloride, United States Pharmacopeia (USP) Reference Standard
RP17875
s1227
SAM002548975
SC-20043
SCHEMBL19077
SMR000058508
SR-01000076102
SR-01000076102-2
ST24020666
ST51054041
Study Drug, raloxifene HCI
TC-063566
Tox21_110255
Tox21_110255_1
Tox21_302369
Tox21_501051
UNII-4F86W47BR6
V1611
VA11647

US Patents and Regulatory Information for RALOXIFENE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms RALOXIFENE HYDROCHLORIDE raloxifene hydrochloride TABLET;ORAL 208206-001 Apr 8, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs Inc RALOXIFENE HYDROCHLORIDE raloxifene hydrochloride TABLET;ORAL 200825-001 Jan 21, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Invagen Pharms RALOXIFENE HYDROCHLORIDE raloxifene hydrochloride TABLET;ORAL 090842-001 Sep 24, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd RALOXIFENE HYDROCHLORIDE raloxifene hydrochloride TABLET;ORAL 204310-001 Aug 28, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
UBS
Teva
Cerilliant
Merck
Federal Trade Commission
Fuji
QuintilesIMS
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.